Latest Insider Transactions at Frequency Therapeutics, Inc. (FREQ)
This section provides a real-time view of insider transactions for Frequency Therapeutics, Inc. (FREQ). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Frequency Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Frequency Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2020
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,000
-11.14%
|
$280,000
$35.0 P/Share
|
|
Dec 14
2020
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct |
13,514
-4.01%
|
$472,990
$35.12 P/Share
|
|
Dec 14
2020
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
13,514
+3.85%
|
$0
$0.61 P/Share
|
|
Dec 09
2020
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct |
13,514
-4.01%
|
$432,448
$32.93 P/Share
|
|
Dec 09
2020
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
13,514
+3.85%
|
$0
$0.61 P/Share
|
|
Dec 08
2020
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct |
8,848
-1.34%
|
$274,288
$31.24 P/Share
|
|
Dec 08
2020
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
8,848
+2.59%
|
$0
$0.61 P/Share
|
|
Dec 07
2020
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct |
4,666
-1.42%
|
$139,980
$30.02 P/Share
|
|
Dec 07
2020
|
David L. Lucchino |
BUY
Exercise of conversion of derivative security
|
Direct |
4,666
+1.4%
|
$0
$0.61 P/Share
|
|
Dec 01
2020
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct |
15,714
-2.32%
|
$439,992
$28.28 P/Share
|
|
Nov 17
2020
|
Robert Langer Director |
SELL
Bona fide gift
|
Direct |
56,912
-20.98%
|
-
|
|
Nov 09
2020
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,000
-10.03%
|
$192,000
$24.0 P/Share
|
|
Nov 05
2020
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,000
-9.11%
|
$184,000
$23.0 P/Share
|
|
Nov 02
2020
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct |
15,714
-2.23%
|
$329,994
$21.05 P/Share
|
|
Oct 13
2020
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,000
-8.35%
|
$176,000
$22.0 P/Share
|
|
Oct 08
2020
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,000
-7.71%
|
$168,000
$21.12 P/Share
|
|
Oct 07
2020
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,000
-7.16%
|
$160,000
$20.0 P/Share
|
|
Oct 06
2020
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,000
-6.68%
|
$152,000
$19.46 P/Share
|
|
Oct 05
2020
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,000
-6.26%
|
$144,000
$18.35 P/Share
|
|
Oct 02
2020
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,000
-5.89%
|
$144,000
$18.92 P/Share
|
|
Oct 01
2020
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct |
15,716
-2.14%
|
$298,604
$19.29 P/Share
|
|
Oct 01
2020
|
Christopher R. Loose Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,000
-5.56%
|
$144,000
$18.84 P/Share
|
|
Oct 07
2019
|
James E Flynn > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
285,714
+50.0%
|
$3,999,996
$14.0 P/Share
|
|
Oct 07
2019
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
945,720
+50.0%
|
-
|